The following is a statement from the CEO of Blythedale Children’s Hospital: Congress is debating the…
Category: Primers
Winner Medical to Showcase Innovations in Wound Care and Infection Prevention at MEDICA 2021
Winner Medical (300888.SZ), a leading manufacturer for disposable wound care and surgical products, is set to…
School Children Call on PA Officials to Drop Mask Mandate
– Attorneys working with The Amistad Project presented arguments before the Commonwealth Court of Pennsylvania today contending that Acting…
Meet the Next Resolution in Medicine — Polaris Biology Releases Starion™, the next-generation mass cytometer
Polaris Biology, a leading innovator in single-cell technologies, announced today the largest product launch in company…
Columbia China opens its third and largest hospital in Jiaxing, China
Columbia China, a joint venture between Seattle’s Columbia Pacific Management, Sheares Healthcare Group, a 100% owned subsidiary of Singapore investment company…
Momentum Grows for Morreale Healthcare Practice with International Award Recognition
Morreale Communications has been honored with two Gold Stevie® Awards for Community Involvement Program of the Year…
Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
Johnson & Johnson (NYSE: JNJ) today announced the appointment of Jessica Moore to Vice President of Investor Relations for…
Ignore No More: Foundation for Sarcoidosis Research Launches African American Women & Sarcoidosis Campaign
The Foundation for Sarcoidosis Research (FSR) is excited to announce the official launch of the first…
AANA Underscores Need for Policies to Improve Competition in Healthcare in Letter to Biden Administration
In an Oct. 5 letter to President Biden, American Association of Nurse Anesthesiology (AANA) President Dina Velocci, DNP, CRNA,…
Oblique Therapeutics is excited to present the recent progress on its anti-Thioredoxin mAb program at the annual meeting of Society for Immunotherapy of Cancer, Nov 10 – 14, Washington DC, USA
Oblique Therapeutics, a biotech focused on new medicines for severe diseases with large unmet medical needs,…